| S7505 |
(S)-crizotinib
|
(S)-crizotinib, the (S)-enantiomer of crizotinib, is a potent MTH1 (NUDT1) inhibitor with IC50 of 72 nM in a cell-free assay.
|
-
iScience, 2024, 27(10):110862
-
Bio Protoc, 2023, 10.21769/BioProtoc.4870
-
Am J Respir Crit Care Med, 2020, 10.1164/rccm.202003-0627OC
|
|
| S7632 |
TH588
|
TH588 is a potent and selective MTH1 (NUDT1) inhibitor with IC50 of 5 nM. It has no relevant inhibition of any of the other tested proteins at 100 μM, although this compound showed reasonable selectivity when tested on a much larger panel of 87 enzymes, GPCRs, kinases, ion channels and transporters at 10 μM.
|
-
Adv Healthc Mater, 2024, e2402349.
-
Colloids Surf B Biointerfaces, 2022, 218:112715
-
Cell Syst, 2019, 9(1):74-92.e8
|
|
| S7631 |
TH287
|
TH287 is a potent and selective MTH1 (NUDT1) inhibitor with IC50 of 0.8 nM.
|
-
Nat Commun, 2024, 15(1):2377
-
Breast Cancer Res, 2022, 24(1):41
-
Oncogene, 2021, 10.1038/s41388-021-02105-9
|
|